Mireia Raluy Callado
Since joining the company in September 2007, Mireia has focused on the design and execution of retrospective observational studies using statistical and econometric modeling to analyze existing data across several European countries. In support of real-world evidence generation, she has led and designed several types of studies including descriptive cohort studies on the burden and epidemiology of a disease, post-authorization drug utilization and safety studies, and comparative assessment of treatment effects. Her experience expands across several therapeutic areas, such as diabetes, COPD, and gastrointestinal disorders, and her work has been widely published in peer-reviewed journals. Mireia has also worked with clinical trial and registry data, and has gained experience in rare diseases including development and psychometric analysis of patient and clinician-reported outcomes.
Prior to her current role, Mireia worked at the IESE Business School, in the public-private sector research center of the economics department, collaborating on health economics projects. These included a comparison of different health systems through self-reported health indexes, and an econometric model to assess whether hospital mergers in the U.S. between 1985 and 2000 could be explained by the willingness to adopt new technologies.
Mireia holds a bachelor’s degree in economics from Pompeu Fabra University and an MSc in economics from the London School of Economics and Political Science. She is a native Catalan and Spanish speaker and is fluent in English.